Metabolic |
α-amylase |
Kinetic |
Salimetrics (1-1902) |
saliva |
Major salivary enzyme that hydrolyzes polysaccharides to glucose and maltose. |
Biomarker of sympathetic nervous system; elevated levels linked to stress (Nater and Rohleder 2009). |
Metabolic |
Uric acid |
Kinetic |
Salimetrics (1-3802) |
serum |
Product of metabolic breakdown of purine nucleotides. |
Elevated levels linked to gout, kidney stones and diabetes (Dehghan et al. 2008); low levels may be linked to depression (Jimenez-Fernandez et al. 2015). |
Metabolic |
Low density lipoprotein (LDL) |
Enzyme-linked immunosorbent assay (ELISA) |
Cell Biolabs (STA-391) |
serum |
“Bad cholesterol”; lipoprotein synthesized in the liver; transports cholesterol to tissues; can be deposited in the walls of blood vessels and contribute to atherosclerosis. |
Elevated serum LDL contributes to the pathogenesis of atherosclerosis (Hansson and Hermansson 2011). |
Metabolic |
High density lipoprotein (HDL) |
ELISA |
Cell Biolabs (STA-391) |
serum |
“Good cholesterol”; transports cholesterol from tissues to the liver. |
HDL has vascular protective effects; reduces the risk of atherosclerosis (Luscher et al. 2014). High HDL in combination with low SAA is predictive of reduced mortality risk (Zewinger et al. 2015). |
Metabolic |
Serum amyloid A (SAA) |
MSD V-plex vascular injury panel |
MSD (K15198G-1) |
serum |
Family of apolipoproteins associated with HDL and secreted during acute phase of inflammation; involved in recruitment of immune cells to inflammatory sites. |
High levels linked to inflammatory diseases, diabetes (Marzi et al. 2013), CVD and death (Johnson et al. 2004; Zamani et al. 2013). |
Immune |
C-reactive protein (CRP) |
MSD V-plex vascular injury panel |
MSD (K15198G- 1) |
serum |
Protein synthesized in the liver; enhances phagocytosis during acute phase reactions that promote inflammation. |
Elevated in chronic inflammatory diseases; risk factor for CVD and death (Barron et al. 2015; Koenig et al. 1999; Zengin et al. 2015). |
Immune |
Vascular cell adhesion molecule 1 (VCAM-1) |
MSD V-plex vascular injury panel |
MSD (K15198G- 1) |
serum |
Protein consisting of immunoglobulin domains; expressed in blood vessels upon cytokine stimulation; promotes adhesion of lymphocytes to vascular endothelium. |
Elevated levels linked to CVD and risk of death (Zamani et al. 2013). |
Immune |
Intercellular adhesion molecule 1 (ICAM-1) |
MSD V-plex vascular injury panel |
MSD (K15198G- 1) |
serum |
Immunoglobulin glycoprotein produced by vascular endothelium and leukocytes; induced by IL-1 and TNF; produces pro-inflammatory effects through cell signaling. |
Elevated levels linked with chronic inflammation, diabetes (Gu et al. 2012), stroke and risk of death (Schnabel et al. 2013). |
Immune |
Interleukin (IL)-1β |
MSD U-plex pro-inflammatory cytokines panel |
MSD (K15053K- 1) |
serum |
Cytokine protein produced by activated macrophages; mediator of inflammatory responses; involved in cell proliferation, differentiation, and apoptosis. |
Central regulator of stress response affecting levels of other stress biomarkers (Goshen and Yirmiya 2009); involved in pathogenesis of atherosclerosis (Hansson and Hermansson 2011). |
Immune |
IL-6 |
MSD U-plex pro-inflammatory cytokines panel |
MSD (K15053K- 1) |
serum |
Cytokine produced by macrophages and T-cells; stimulates B cell and T cell differentiation in acute phase response to tissue damage; produces fever. |
Drive production of reactant proteins, including CRP; elevated levels linked to major depressive disorder (Haapakoski et al. 2015) and higher risk of death in CVD patients (Zamani et al. 2013). |
Immune |
IL-8 |
MSD U-plex pro-inflammatory cytokines panel |
MSD (K15053K- 1) |
serum |
Cytokine produced by macrophages; mediator of pro-inflammatory response; induces chemotaxis and phagocytosis by immune cells at infection sites. |
Elevated levels linked with inflammation, obesity and increased risk of death (Cavusoglu et al. 2015). |
Immune |
TNF-α |
MSD U-plex pro-inflammatory cytokines panel |
MSD (K15053K- 1) |
serum |
Cytokine produced by macrophages; functions in systemic inflammation by evoking mediators of acute phase reactions as well as in tumor apoptosis. |
Produces fever; used pharmacologically; elevated levels linked to autoimmune disorders and major depressive disorder (Haapakoski et al. 2015). |
Immune |
Fibrinogen |
ELISA |
Abcam (ab108842) |
serum |
Protein that synthesizes into fibrin in the liver; functions as a blood clotting factor that promotes coagulation. |
Elevated levels linked to thrombosis, CVD, and increased risk of death (Barron et al. 2015; Kunutsor et al. 2016). |
Immune |
Myeloperoxidase (MPO) |
ELISA |
Abcam (ab119605) |
serum |
Peroxidase enzyme produced by activated neutrophils, monocytes and macrophages. Catalyzes the modification of LDL. |
Elevated levels linked to coronary artery disease (Zakynthinos and Pappa 2009). |
Neuroendocrine |
Dehydroepiandrosterone (DHEA) |
ELISA |
Salimetrics (11202) |
serum |
Steroid hormone; precursor of sex hormones; suppresses inflammation; improves lipid metabolism; decreases insulin resistance; reduces oxidative brain damage. |
Low levels linked to coronary heart disease (Tivesten et al. 2014), immune disorder and increased risk of death (Ohlsson et al. 2015). |
Neuroendocrine |
Epinephrine |
ELISA |
Eagle Biosciences (AND31-K03) |
serum |
Catecholamine produced by adrenal glands and brain; increases heart rate and glucose levels, decreases digestive and immune functions during “fight- or-flight” response. |
Increased in acute stress and exercise; used to treat cardiac arrest and allergic reactions. Inconsistent reports on associations with burnout and depression; high levels indicative of AL in previous studies (Juster et al. 2010; Juster et al. 2011). |
Neuroendocrine |
Norepinephrine |
ELISA |
Eagle Biosciences (AND31-K03) |
serum |
Catecholamine produced by the brain; increases blood pressure, constricts blood vessels, and modulates brain activities during “fight-or-flight” response. |
Increases alertness, heart rate and blood pressure; increased in stress (Gu et al. 2016); high level can be predictive of CVD (Yufu et al. 2014); low levels linked with depression (Moret and Briley 2011). |
Neuroendocrine |
Dopamine |
ELISA |
Eagle Biosciences (AND31-K03) |
serum |
Catecholamine produced in the brain and adrenal glands; involved in motivation, voluntary movement, and cognition; increases blood pressure and heart rate. |
Major role in reward pathways in brain; used to treat cardiac arrest; low levels linked to depression (Dunlop and Nemeroff 2007; Kapur and Mann 1992). |